Tislelizumab Plus Chemotherapy vs Chemotherapy Alone as First-line Treatment for Advanced Squamous Non-Small-Cell Lung Cancer A Phase 3 Randomized Clinical Trial

Wang, J; Lu, S; Yu, XM; Hu, YP; Sun, YP; Wang, ZJ; Zhao, J; Yu, Y; Hu, CH; Yang, KY; Feng, GS; Ying, KJ; Zhuang, W; Zhou, JY; Wu, JX; Leaw, SJ; Zhang, J; Lin, X; Liang, L; Yang, N

Wang, J (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, State Key Lab Mol Oncol, Dept Med Oncol, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, 17 Pan Jia Yuan South Lane, Beijing 100021, Peoples R China.

JAMA ONCOLOGY, 2021; 7 (5): 709

Abstract

IMPORTANCE This study demonstrates that tislelizumab in combination with chemotherapy is associated with improved progression-free survival (PFS) in p......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索